The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins

Authors

Joseph A. Califano, Greater Baltimore Medical Center (GBMC)
John M. Saunders, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Clinical Cancer Research

First Page

7658

Last Page

7665

DOI

https://doi.org/10.1158/1078-0432.ccr-09-1433

Publication Date

12-15-2009

Comments

M Luana Poeta 1, Judith Manola, David Goldenberg, Arlene Forastiere, Joseph A Califano, John A Ridge, Jarrard Goodwin, Daniel Kenady, John Saunders, William Westra, David Sidransky, Wayne M Koch

Affiliation

• 1Authors' Affiliations: Johns Hopkins University and Greater Baltimore Medical Center, Baltimore, Maryland; Dana-Farber Cancer Institute, Boston, Massachusetts; Pennsylvania State Hershey Medical Center, Hershey, Pennsylvania; Fox Chase Cancer Center, Philadelphia, Pennsylvania; University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida; University of Kentucky, Lexington, Kentucky; and Department of General and Environmental Physiology, Centre of Excellence in Comparative Genomics (CEGBA), University of Bari, Bari, Italy.

Recommended Citation

Poeta ML, Manola J, Goldenberg D, Forastiere A, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins. Clin Cancer Res. 2009 Dec 15;15(24):7658-7665. doi: 10.1158/1078-0432.CCR-09-1433. PMID: 19996217; PMCID: PMC2842212.